Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00590317Phase 2Completed
Phase 2, randomised, double-blind trial of ondansetron in nausea ((none)) and Vomiting (2 arms), sponsored by Emory University. Primary endpoint: Vomiting at 0 to 120 Min. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00590317.